Lv5
1110 积分 2021-12-01 加入
Inflammatory age and its impact on age-related health in older Chinese adults
22天前
已完结
Dinutuximab beta in high-risk neuroblastoma: a profile of its use
23天前
已完结
Degrader-antibody conjugates
28天前
已完结
Degrader–Antibody Conjugates: Emerging New Modality
28天前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
28天前
已完结
Methylenedioxymethamphetamine (MDMA) in Psychiatry
2个月前
已关闭
Neurological and cognitive alterations induced by MDMA in humans
2个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
2个月前
已完结
Is lirentelimab the ‘magic bullet’ to fight pathological mast-cell activation in systemic mastocytosis?
2个月前
已完结
Is lirentelimab the ‘magic bullet’ to fight pathological mast-cell activation in systemic mastocytosis?
2个月前
已关闭
皖公网安备34019202002308
